|
Phase III Study of Crizotinib vs. Chemotherapy in Advanced ALK+ NSCLC: Patient-Reported Symptoms and Quality of Life |
|
|
|
Title: |
Phase III Study of Crizotinib vs. Chemotherapy in Advanced ALK+ NSCLC: Patient-Reported Symptoms and Quality of Life |
Author: |
Nokihara, H. Hirsh, V. Blackhall, F. Kim, D.-W. Besse, B. Han, J.-Y. Wilner, K. Reisman, A. Iyer, S. Shaw, A. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 24 () nr. S9 pages ix43 |
Year: |
2013 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|